JCC:IBD患者营养不良发生率与营养状况评价

2017-07-30 xuyihan MedSci原创

明确炎症性肠病(IBD)患者营养不良的流行情况,分析这些患者的饮食结构和行为,研究其身体组成成分,评估其肌肉力量,并试图找到这些患者营养不良相关的危险因素。

研究目的:明确炎症性肠病IBD)患者营养不良的流行情况,分析这些患者的饮食结构和行为,研究其身体组成成分,评估其肌肉力量,并试图找到这些患者营养不良相关的危险因素。

研究方法:纳入包括来自门诊与住院的30个西班牙医疗中心的克罗恩病溃疡性结肠炎患者。使用11项调查问卷,收集患者的饮食结构和行为数据,使用主观评估问卷和体重身高指数评估患者的营养状况,通过生物电阻抗仪器评估患者机体组成。

结果展示:共纳入1271例患者(51%女性,中位年龄45岁,克罗恩病占60%)。333名患者进行了营养评估。共有77%的病人会自觉避免食用一些食物,以预防疾病复发。有86%的患者因疾病恶化拒绝食用某些食物。 67%的患者在疾病诊断后改变了饮食习惯。营养不良患病率为16%。在多变量分析中,存在腹部手术史,处于疾病活动期和避孕期间的某些食物与营养不良的危险相关性较高。

结论:炎症性肠病患者营养不良患病率较高,大多数患者会根据自己的身体情况自己选择食用的食物。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826371, encodeId=1c4818263e1da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Jun 17 17:46:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263443, encodeId=4d55126344363, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Tue Aug 01 13:46:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444239, encodeId=1a25144423963, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Aug 01 13:46:00 CST 2017, time=2017-08-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1826371, encodeId=1c4818263e1da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Jun 17 17:46:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263443, encodeId=4d55126344363, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Tue Aug 01 13:46:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444239, encodeId=1a25144423963, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Aug 01 13:46:00 CST 2017, time=2017-08-01, status=1, ipAttribution=)]
    2017-08-01 bnurmamat
  3. [GetPortalCommentsPageByObjectIdResponse(id=1826371, encodeId=1c4818263e1da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Jun 17 17:46:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263443, encodeId=4d55126344363, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Tue Aug 01 13:46:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444239, encodeId=1a25144423963, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Aug 01 13:46:00 CST 2017, time=2017-08-01, status=1, ipAttribution=)]
    2017-08-01 huagfeg

相关资讯

INFLAMM BOWEL DIS:粪便钙卫蛋白检测在无症状炎症性肠病患者中的临床应用现状

在无症状的炎症性肠病(IBD)患者中,一般通过反复地进行各种检查以期望尽早识别疾病是否发生了恶化。其中反映肠道炎症状况的粪钙卫蛋白(FC)可以有效预测IBD复发的的情况。

Inflamm Bowel Dis:静脉注射免疫球蛋白治疗难治性炎症性肠病患者的疗效及因素

静脉注射免疫球蛋白(IVIG)的给药方式已被证明在治疗难治性炎症性肠病(IBD)方面是有希望的。本项研究旨在确定治疗难治性IBD时IVIG失败相关的因素。